Side Effects, Warnings, and When to Seek Help Escitalopram can cause side effects
Diabetes Care, 2026 The results across four cardiovascular endpoints in the primary propensity score-adjusted analysis: MACE-3 (CV death, MI, or stroke): HR 0.72 (95% CI 0.550.94), p=0.016 a 28% reduction vs
10.3389/fphar.2020.566611 252 TungsangaS.KatavetinP.PanpetchW.UdompornpitakK.SaisornW.PraditpornsilpaK.et al (2022)
GLP-1 Use in Type 1 Diabetes: Where Adjunct Therapy Mayand May NotMake Sense Apr 10, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Therapies, Type 1 Diabetes, Type 1 Diabetes 1,473 views GLP-1 receptor agonists as adjunct therapy in type 1 diabetes are gaining attention as clinicians look for new ways to improve glycemic control
R.DenekeE.WassermanE